Amgen Inc. Canadian Depositary Receipt (AMGN)
NEO
Closed
Aug 20, 2026
Day's Range
32.1052 wk Range
20.46Overview - AMGN - Amgen Inc. Canadian Depositary Receipt
Key Statistics
Valuation
Enterprise Value
361.57B
P/E (Trailing)
‪38.21‬
PEG Ratio
‪0.58‬
Price / Sales (TTM)
‪9.26‬
Price / Book
‪2.78‬
EV / EBITDA
‪21.39‬
Profitability
Gross Margin
‪72.04%‬
Profit Margin
‪17.38%‬
Operating Margin
‪28.72%‬
Return on Assets
‪7.03%‬
Return on Equity
‪105.67%‬
Ownership
Shares Outstanding
541.00M
Float
536.33M
Price stats
Beta
‪0.49‬
50-Day Avg
‪24.58‬
200-Day Avg
‪22.64‬
Dividends
Payout Ratio
‪0.00%‬
Frequency
Quarterly
Shariah Compliance
Report Date: Feb 19, 2025
Screened by Zoya using the AAOIFI methodology.
Peers - AMGN - Amgen Inc. Canadian Depositary Receipt
Peer Comparison
Compared with companies in Drug Manufacturers - General listed on NEO.
Profile Summary - AMGN - Amgen Inc. Canadian Depositary Receipt
About
Amgen Inc. Canadian Depositary Receipt (CDR) is a financial instrument that provides Canadian investors with exposure to Amgen Inc., a leading biotechnology company focused on developing innovative human therapeutics. This CAD-hedged CDR represents fractional ownership of Amgen Inc. common stock through a dynamic CDR…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
